These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2009149)

  • 1. Long-term effects of delapril on renal function and urinary excretion of kallikrein, prostaglandin E2, and thromboxane B2 in hypertensive patients.
    Nishiyama K; Igari T; Nanba S; Ishii M
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):52S-53S. PubMed ID: 2009149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The long-term effects of a new converting enzyme inhibitor, delapril hydrochloride, on renal function, renin-angiotensin-aldosterone system and kallikrein-kinin prostaglandin system in hypertensive patients].
    Nishiyama K; Igari T; Nanba S; Ishii M
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):801-7. PubMed ID: 2273596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats.
    Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Laitinen LA; Manninen V; Ylitalo P; Vapaatalo H
    Scand J Urol Nephrol Suppl; 1984; 79():23-7. PubMed ID: 6089314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
    Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
    Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary observations of the acute effects of selective serum thromboxane inhibition and angiotensin converting enzyme inhibition on blood pressure and renal hemodynamics in hypertensive humans.
    Weir MR; Klassen DK; Hoover N; Douglas FL
    J Clin Pharmacol; 1989 Dec; 29(12):1108-16. PubMed ID: 2693500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
    Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
    J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine increases urinary excretion of prostacyclin metabolite in hypertensive pregnancy.
    Manninen A; Metsä-Ketelä T; Tuimala R; Vapaatalo H
    Pharmacol Toxicol; 1991 Jul; 69(1):60-3. PubMed ID: 1946195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiotensin-converting enzyme with quinapril (CI-906): investigation of antihypertensive mechanisms in spontaneously hypertensive rats.
    Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Metsä-Ketelä T; Tuomisto L; Manninen V; Vapaatalo H
    J Pharmacol Exp Ther; 1986 Apr; 237(1):246-51. PubMed ID: 3007740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary kallikrein excretion and blood pressure response to angiotensin converting enzyme inhibitors and calcium antagonists in hypertensive patients.
    Dessì-Fulgheri P; Espinosa E; Zingaretti O; Guazzarotti F; Sarzani R; Pupita G; Sturbini S; Catalini R; Rappelli A
    J Hypertens; 1993 Jul; 11(7):725-30. PubMed ID: 8228191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin, kallikrein and prostaglandin renal systems in normotensive boys with and without a family history of essential hypertension.
    Rey C; Santos F; Málaga S; Orejas G; Simarro M; Crespo M
    J Cardiovasc Risk; 1995 Apr; 2(2):143-8. PubMed ID: 7606651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.
    Schiffrin EL; Gutkowska J; Thibault G; Genest J
    Can J Physiol Pharmacol; 1984 Jan; 62(1):116-23. PubMed ID: 6143602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of orally administered glandular kallikrein on urinary kallikrein and prostaglandin excretion, plasma immunoreactive prostanoids and platelet aggregation in essential hypertension.
    Ogawa K; Ito T; Ban M; Mochizuki M; Satake T
    Klin Wochenschr; 1985 Apr; 63(7):332-6. PubMed ID: 3889484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary prostaglandin E2 and kallikrein excretion in glucocorticoid hypertension in rats.
    Handa M; Kondo K; Suzuki H; Saruta T
    Clin Sci (Lond); 1983 Jul; 65(1):37-42. PubMed ID: 6342908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antihypertensive mechanism of delapril, a newly developed converting enzyme inhibitor, is related to the suppression of vascular angiotensin II release in the spontaneously hypertensive rat.
    Mizuno K; Tani M; Niimura S; Yamaguchi M; Inagami T; Fukuchi S
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):60S-66S. PubMed ID: 2009151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of short-term administration of cromakalim on renal hemodynamics and eicosanoid excretion in essential hypertension.
    Lebel M; Grose JH; Lacourcière Y
    Am J Hypertens; 1991 Sep; 4(9):740-4. PubMed ID: 1834087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
    Hosoki K; Takeyama K; Minato H; Fukuya F; Kawahara S; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):77-83. PubMed ID: 3006712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and tissue kallikrein-kinin systems during acute administration of frusemide in normotensive and hypertensive humans.
    Ohman KP; Karlberg BE
    Clin Sci (Lond); 1991 Sep; 81(3):305-11. PubMed ID: 1655330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rational criteria for the choice of ACE inhibitor adapted to the individual hypertensive patient].
    Rappelli A; Dessì-Fulgheri P
    Ann Ital Med Int; 1993 Oct; 8 Suppl():105S-106S. PubMed ID: 8117516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of aging on urinary kallikreins and other vasoactive substances in essential hypertension.
    Fang S; Abe K; Omata K; Yasujima M; Yoshinaga K
    Adv Exp Med Biol; 1989; 247B():139-44. PubMed ID: 2692411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.